Prognostic value of immunohistochemical expression of p53, bax, Bcl‐2 and Bcl‐xL in resected non‐small‐cell lung cancers
Authors:
- 7 January 2004
- journal article
- Published by Wiley in Histopathology
- Vol. 44 (1) , 54-63
Abstract
Aims : Some experimental evidence suggests that in lung cancer, development, progression and an increased proliferation rate can be linked to apoptosis‐related factors. In this study we evaluated the possible role of p53 and Bcl‐2 gene family members as prognostic factors for non‐small‐cell lung cancer.Methods and results : We investigated the immunohistochemical expression of p53 and Bcl‐2 gene family members (bax, Bcl‐2 and Bcl‐xL) in 94 non‐small‐cell lung cancer specimens to establish the role of these genes in lung cancer pathogenesis, and to evaluate their prognostic importance. The expression of Bcl‐2 was correlated with a shorter patient survival time and with the nodal status of the neoplasm. We also found frequent over‐expression of bax and Bcl‐xL to be of no prognostic significance. Finally, we found no correlation between frequent detection of aberrant p53 protein and expression of either Bcl‐2, bax or Bcl‐xL or with patient survival time.Conclusions : This study confirms a relevant role for apoptosis‐regulatory proteins in the pathogenesis of lung cancer, and highlights the possible role of Bcl‐2 as a prognostic factor for this tumour.Keywords
This publication has 20 references indexed in Scilit:
- The p53 network in lung carcinogenesisOncogene, 2002
- Immunohistochemical demonstration of apoptosis-regulated proteins, Bcl-2 and Bax, in resected non-small-cell lung cancersInternational Journal of Clinical Oncology, 2002
- Molecular Pathogenesis of Lung CancerAnnual Review of Physiology, 2002
- Does immunointensity account for the differences in prognostic significance of Bcl-2 expression in non-small cell lung cancer?Pathology and Oncology Research, 2000
- Multiple Bcl-2 family members demonstrate selective dimerizations with Bax.Proceedings of the National Academy of Sciences, 1995
- Immunohistochemical detection of p53 protein is not associated with a poor prognosis in non-small-cell lung cancerThe Journal of Thoracic and Cardiovascular Surgery, 1995
- Implications of apoptotic cell death regulation in cancer therapySeminars in Cancer Biology, 1995
- bcl-2 Protein in Non-Small-Cell Lung CarcinomaNew England Journal of Medicine, 1993
- Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell deathCell, 1993
- bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell deathCell, 1993